Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,525 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Potent antitumor immunity generated by a CD40-targeted adenoviral vaccine.
Hangalapura BN, Oosterhoff D, de Groot J, Boon L, Tüting T, van den Eertwegh AJ, Gerritsen WR, van Beusechem VW, Pereboev A, Curiel DT, Scheper RJ, de Gruijl TD. Hangalapura BN, et al. Among authors: de groot j, de gruijl td. Cancer Res. 2011 Sep 1;71(17):5827-37. doi: 10.1158/0008-5472.CAN-11-0804. Epub 2011 Jul 11. Cancer Res. 2011. PMID: 21747119 Free article.
Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an adenovirus based melanoma vaccine.
Hangalapura BN, Oosterhoff D, Gupta T, de Groot J, Wijnands PG, van Beusechem VW, den Haan J, Tüting T, van den Eertwegh AJ, Curiel DT, Scheper RJ, de Gruijl TD. Hangalapura BN, et al. Among authors: de groot j, de gruijl td. Vaccine. 2011 Mar 9;29(12):2313-21. doi: 10.1016/j.vaccine.2011.01.022. Epub 2011 Jan 25. Vaccine. 2011. PMID: 21272606 Free PMC article.
Unimpaired immune functions in the absence of Mrp4 (Abcc4).
van de Ven R, de Groot J, Reurs AW, Wijnands PG, van de Wetering K, Schuetz JD, de Gruijl TD, Scheper RJ, Scheffer GL. van de Ven R, et al. Among authors: de groot j, de gruijl td. Immunol Lett. 2009 Jun 4;124(2):81-7. doi: 10.1016/j.imlet.2009.04.007. Epub 2009 May 3. Immunol Lett. 2009. PMID: 19406153
Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide.
Bontkes HJ, Moreno M, Hangalapura B, Lindenberg JJ, de Groot J, Lougheed S, van der Vliet HJ, van den Eertwegh AJ, de Gruijl TD, von Blomberg BM, Scheper RJ. Bontkes HJ, et al. Among authors: de groot j, de gruijl td. Clin Immunol. 2010 Sep;136(3):364-74. doi: 10.1016/j.clim.2010.04.019. Epub 2010 Jun 8. Clin Immunol. 2010. PMID: 20570567
Unimpaired dendritic cell functions in MVP/LRP knockout mice.
Mossink MH, de Groot J, van Zon A, Fränzel-Luiten E, Schoester M, Scheffer GL, Sonneveld P, Scheper RJ, Wiemer EA. Mossink MH, et al. Among authors: de groot j. Immunology. 2003 Sep;110(1):58-65. doi: 10.1046/j.1365-2567.2003.01708.x. Immunology. 2003. PMID: 12941141 Free PMC article.
Assessment of contact allergen cross-reactivity by retesting.
Rustemeyer T, de Groot J, von Blomberg BM, Bruynzeel DP, Frosch PJ, Scheper RJ. Rustemeyer T, et al. Among authors: de groot j. Exp Dermatol. 2002 Jun;11(3):257-65. doi: 10.1034/j.1600-0625.2001.110309.x. Exp Dermatol. 2002. PMID: 12102665
Cross-reactivity patterns of contact-sensitizing methacrylates.
Rustemeyer T, de Groot J, von Blomberg BM, Frosch PJ, Scheper RJ. Rustemeyer T, et al. Among authors: de groot j. Toxicol Appl Pharmacol. 1998 Jan;148(1):83-90. doi: 10.1006/taap.1997.8304. Toxicol Appl Pharmacol. 1998. PMID: 9465267
1,525 results